The results indicate that the nomogram based on HE medel, Ki67 model, and clinical variables, as well as the HE_Ki67 model, both demonstrate higher net benefits for classifying Stages I–II and Stage III colorectal cancer in both the training and testing cohorts compared to the HE model and Ki67 model. Here, MKI67 is linked to colorectal cancer.